| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA518818
Max Phase: Preclinical
Molecular Formula: C18H14O5
Molecular Weight: 310.31
Molecule Type: Small molecule
Associated Items:
Representations
Synonyms (1): ST-2933
Synonyms from Alternative Forms(1):
Canonical SMILES: COc1cc(/C=C\c2cc(O)c3ccoc3c2)cc2c1OCO2
Standard InChI: InChI=1S/C18H14O5/c1-20-16-8-12(9-17-18(16)23-10-22-17)3-2-11-6-14(19)13-4-5-21-15(13)7-11/h2-9,19H,10H2,1H3/b3-2-
Standard InChI Key: CMSXMODBOIWVBO-IHWYPQMZSA-N
Associated Targets(non-human)
BMEC (52 Activities)
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 310.31 | Molecular Weight (Monoisotopic): 310.0841 | AlogP: 4.05 | #Rotatable Bonds: 3 |
| Polar Surface Area: 61.06 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 8.27 | CX Basic pKa: | CX LogP: 3.63 | CX LogD: 3.58 |
| Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.74 | Np Likeness Score: 1.02 |
References
| 1. Simoni D, Romagnoli R, Baruchello R, Rondanin R, Grisolia G, Eleopra M, Rizzi M, Tolomeo M, Giannini G, Alloatti D, Castorina M, Marcellini M, Pisano C.. (2008) Novel A-ring and B-ring modified combretastatin A-4 (CA-4) analogues endowed with interesting cytotoxic activity., 51 (19): [PMID:18783207] [10.1021/jm8005004] |
Source
Source(1):